SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-040137
Filing Date
2024-09-11
Accepted
2024-09-11 16:34:00
Documents
16
Period of Report
2024-09-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20240911.htm   iXBRL 8-K 32747
2 EX-99.1 csbr8-k7312024ex991xq125.htm EX-99.1 132345
7 logobranding_headerleftali.jpg GRAPHIC 32167
  Complete submission text file 0001628280-24-040137.txt   342162

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20240911.xsd EX-101.SCH 2186
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20240911_def.xml EX-101.DEF 2872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20240911_lab.xml EX-101.LAB 21002
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20240911_pre.xml EX-101.PRE 12628
18 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20240911_htm.xml XML 2446
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 241293011
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)